The release of β‐catenin, triggered by the loss of cadherin‐mediated cell adhesion, has been extensively indicated in the literature to serve as a pivotal modulator engaged in EMT in numerous cancer cells 17, 55. The gene discussed is CDH17; the disease is cancer.